Anthem Biosciences' $395m IPO fully subscribed as investors bet on Indian pharma

FILE PHOTO: People work at the National Stock Exchange (NSE) stall during the Global Fintech Fest in Mumbai, India, August 29, 2024. REUTERS/Francis Mascarenhas/File Photo

Reuters

15 July, 2025

Anthem Biosciences

Printed by Unregistered user on Mon, 08 Dec 2025 23:08:25 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Anthem Biosciences' $395m IPO fully subscribed as investors bet on Indian pharma

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

India's Ahammune Biosciences snags $5m round led by deep tech investor pi Ventures

India: PlasmaGen Biosciences secures $27m from UK's Artian Investments, others

Read more from India

India’s ICICI Prudential AMC plans acquisition in PE space, says CEO

Creador acquires 7% stake in India’s La Renon healthcare from promoter, Peak XV

Anthem Biosciences' $395m IPO fully subscribed as investors bet on Indian pharma

Register Now to Unlock Premium Content

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

India's Ahammune Biosciences snags $5m round led by deep tech investor pi Ventures

India: PlasmaGen Biosciences secures $27m from UK's Artian Investments, others

Read more from India

India’s ICICI Prudential AMC plans acquisition in PE space, says CEO

Creador acquires 7% stake in India’s La Renon healthcare from promoter, Peak XV